1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Thymoma: new trials by email Literature Review of Thymoma trials Research Report on Thymoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers KFA115, pembrolizumab - Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma | Phase 1 | Active not recruiting | Novartis Pharmaceuticals | 126 | 2022-10-26 | 2026-10-20 |
Adenocarcinoma, Clear Cell (1) · Anus Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Intestinal Neoplasms (1) · Kidney Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Mesothelioma (1) · Nasopharyngeal Carcinoma (1)
Adenocarcinoma (1) · Adenoma (1) · Adnexal Diseases (1) · Anus Diseases (1) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
pembrolizumab (1)
Canada (1) · China (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Japan (1) · Singapore (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)